Cerestat blocker of calcium influx from glutamate release in the brain: Phase III trial

Cambridge NeuroScience Inc. (CNSI), Cambridge, Mass. Product: Cerestat blocker of calcium influx from glutamate release in the brain Indication: Stroke Status: CNSI and partner Boehringer Ingelheim be...